Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis.

Pharmgenomics Pers Med · 2022 · PMC8828078 · PMID 35153502

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In particular, ivacaftor and elexacaftor/tezacaftor/ivacaftor appear to be a disease-modifying transformative development in CF care that generates improvements in quality of life and lung health that are clinically highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.